The average one-year price target for Assertio Holdings (NasdaqCM:ASRT) has been revised to $27.80 / share. This is a ...

In the latest trading session, Assertio (ASRT) closed at $1.14, marking a -1.72% move from the previous day. This move lagged the S&P 500's daily gain of 0.19%. At the same time, the Dow added 0.31%, ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Assertio Holdings is back in focus after its fair value estimate was reset from US$37.44 to US$21.33, a cut of roughly 43% that reflects a more cautious stance on the stock. Analysts are weighing this ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Assertio (ASRT) is a stock that can certainly grab the attention of many investors, ...

Detailed price information for Assertio Therapeutics Inc (ASRT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Assertio Therapeutics Inc (ASRT-Q) from The Globe and Mail including charting and trades.

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail ...

Assertio Holdings ASRT will report second-quarter 2022 results on Aug 8, before market open. In the second-quarter 2022 results, we expect investors to focus on the sales performance of Assertio’s ...